ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 51,100
-2,800 (-5.19%)
Sep 22, 2026, 3:30 PM KST
ABL Bio Stock Forecast
KOSDAQ-298380's stock price has decreased by -52.82% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, ABL Bio stock has a consensus rating of "Buy" and an average price target of ₩266,667. The average 1-year stock price forecast is 421.85% higher than the current stock price, while the lowest is ₩260,000 (+408.81%) and the highest is ₩280,000 (+447.95%).
Price Target: ₩266,667 (+421.85%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ABL Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Buy | 4 | 5 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 5 | 5 | 5 | 4 |
Financial Forecast
Revenue This Year
89.00B
from 79.35B
Increased by 12.16%
Revenue Next Year
146.23B
from 89.00B
Increased by 64.31%
EPS This Year
-63.33
from -734.00
EPS Next Year
431.67
from -63.33
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.